VSTM
Price
$9.07
Change
+$0.07 (+0.78%)
Updated
Oct 8, 12:54 PM (EDT)
Capitalization
553.91M
ZLDAF
Price
$0.21
Change
-$0.05 (-19.23%)
Updated
Oct 6 closing price
Capitalization
2.98M
Interact to see
Advertisement

VSTM vs ZLDAF

Header iconVSTM vs ZLDAF Comparison
Open Charts VSTM vs ZLDAFBanner chart's image
Verastem
Price$9.07
Change+$0.07 (+0.78%)
Volume$1.64K
Capitalization553.91M
Zelira Therapeutics
Price$0.21
Change-$0.05 (-19.23%)
Volume$743
Capitalization2.98M
VSTM vs ZLDAF Comparison Chart in %
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VSTM vs. ZLDAF commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSTM is a Hold and ZLDAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (VSTM: $9.00 vs. ZLDAF: $0.21)
Brand notoriety: VSTM and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VSTM: 73% vs. ZLDAF: 152%
Market capitalization -- VSTM: $553.91M vs. ZLDAF: $2.98M
VSTM [@Biotechnology] is valued at $553.91M. ZLDAF’s [@Biotechnology] market capitalization is $2.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VSTM’s FA Score shows that 0 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • VSTM’s FA Score: 0 green, 5 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than ZLDAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VSTM’s TA Score shows that 2 TA indicator(s) are bullish while ZLDAF’s TA Score has 2 bullish TA indicator(s).

  • VSTM’s TA Score: 2 bullish, 6 bearish.
  • ZLDAF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ZLDAF is a better buy in the short-term than VSTM.

Price Growth

VSTM (@Biotechnology) experienced а +1.93% price change this week, while ZLDAF (@Biotechnology) price change was -19.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.29%. For the same industry, the average monthly price growth was +18.13%, and the average quarterly price growth was +86.40%.

Industries' Descriptions

@Biotechnology (+8.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($554M) has a higher market cap than ZLDAF($2.98M). VSTM YTD gains are higher at: 74.081 vs. ZLDAF (-44.752). ZLDAF has higher annual earnings (EBITDA): -3.17M vs. VSTM (-163.52M). VSTM has higher revenues than ZLDAF: VSTM (2.14M) vs ZLDAF (40.9K).
VSTMZLDAFVSTM / ZLDAF
Capitalization554M2.98M18,584%
EBITDA-163.52M-3.17M5,158%
Gain YTD74.081-44.752-166%
P/E RatioN/AN/A-
Revenue2.14M40.9K5,225%
Total Cash164MN/A-
Total Debt84.7MN/A-
FUNDAMENTALS RATINGS
VSTM vs ZLDAF: Fundamental Ratings
VSTM
ZLDAF
OUTLOOK RATING
1..100
828
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3890
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VSTM's Valuation (67) in the Biotechnology industry is in the same range as ZLDAF (92) in the null industry. This means that VSTM’s stock grew similarly to ZLDAF’s over the last 12 months.

VSTM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ZLDAF (100) in the null industry. This means that VSTM’s stock grew similarly to ZLDAF’s over the last 12 months.

VSTM's SMR Rating (100) in the Biotechnology industry is in the same range as ZLDAF (100) in the null industry. This means that VSTM’s stock grew similarly to ZLDAF’s over the last 12 months.

VSTM's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for ZLDAF (90) in the null industry. This means that VSTM’s stock grew somewhat faster than ZLDAF’s over the last 12 months.

VSTM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ZLDAF (100) in the null industry. This means that VSTM’s stock grew similarly to ZLDAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VSTMZLDAF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFH55.420.65
+1.19%
Bread Financial Holdings
ICG1.81-0.06
-3.21%
Intchains Group Limited
WSO396.34-13.65
-3.33%
Watsco
EVTL5.95-0.34
-5.41%
Vertical Aerospace Ltd
KXIN0.67-0.04
-6.00%
Kaixin Holdings

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with ZLDAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then ZLDAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
+4.53%
ZLDAF - VSTM
47%
Loosely correlated
N/A
MDGL - VSTM
37%
Loosely correlated
-1.36%
NKTX - VSTM
36%
Loosely correlated
-4.19%
SYRE - VSTM
35%
Loosely correlated
-3.90%
TVRD - VSTM
33%
Loosely correlated
+0.25%
More